These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 156313)

  • 1. Isoniazid therapy of Huntington disease.
    Perry TL; Wright JM; Hansen S; MacLeod PM
    Neurology; 1979 Mar; 29(3):370-5. PubMed ID: 156313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain amino compounds in a Huntington's disease patient on isoniazid therapy.
    Perry TL; Wall RA; Hansen S
    Neurology; 1985 May; 35(5):755-8. PubMed ID: 3157886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-blind clinical trial of isoniazid in Huntington disease.
    Perry TL; Wright JM; Hansen S; Thomas SM; Allan BM; Baird PA; Diewold PA
    Neurology; 1982 Apr; 32(4):354-8. PubMed ID: 6460947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of isoniazid on cerebrospinal fluid and plasma GABA levels in Huntington's disease.
    Manyam NV; Hare TA; Katz L
    Life Sci; 1980 Apr; 26(16):1303-8. PubMed ID: 6446011
    [No Abstract]   [Full Text] [Related]  

  • 5. Isoniazid-induced elevation of CSF GABA levels and effects on chorea in Huntington's disease.
    Manyam BV; Katz L; Hare TA; Kaniefski K; Tremblay RD
    Ann Neurol; 1981 Jul; 10(1):35-7. PubMed ID: 6455963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Failure of aminooxyacetic acid therapy in Huntington disease.
    Perry TL; Wright JM; Hansen S; Allan BM; Baird PA; MacLeod PM
    Neurology; 1980 Jul; 30(7 Pt 1):772-5. PubMed ID: 6446691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevation of gamma-aminobutyric acid in human brain may increase dopaminergic neuronal function.
    Perry TL; Ito M; Jones K; Hansen S
    Neurosci Lett; 1984 Sep; 50(1-3):67-71. PubMed ID: 6238245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Failure of isoniazid therapy in Huntington disease.
    McLean DR
    Neurology; 1982 Oct; 32(10):1189-91. PubMed ID: 6214730
    [No Abstract]   [Full Text] [Related]  

  • 9. Elevation of brain GABA content by chronic low-dosage administration of hydrazine, a metabolite of isoniazid.
    Perry TL; Kish SJ; Hansen S; Wright JM; Wall RA; Dunn WL; Bellward GD
    J Neurochem; 1981 Jul; 37(1):32-9. PubMed ID: 7252511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of Huntington disease with gamma-acetylenic GABA an irreversible inhibitor of GABA-transaminase: increased CSF GABA and homocarnosine without clinical amelioration.
    Tell G; Böhlen P; Schechter PJ; Koch-Weser J; Agid Y; Bonnet AM; Coquillat G; Chazot G; Fischer C
    Neurology; 1981 Feb; 31(2):207-11. PubMed ID: 6258106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitors of GABA metabolism: implications for Huntington's disease.
    Schwarcz R; Bennett JP; Coyle JT
    Ann Neurol; 1977 Oct; 2(4):299-303. PubMed ID: 152600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of Huntington's chorea with isoniazid.
    Perry TL; MacLeod PM; Hansen S
    N Engl J Med; 1977 Oct; 297(15):840. PubMed ID: 142923
    [No Abstract]   [Full Text] [Related]  

  • 13. Long term treatment of Huntington disease with L-glutamate and pyridoxine.
    Barr AN; Heinze W; Mendoza JE; Perlik S
    Neurology; 1978 Dec; 28(12):1280-2. PubMed ID: 153484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response of the cockroach brain gamma-aminobutyric acid system to isonicotinic acid hydrazide and mercaptopropionic acid.
    Pandey A; Singh R
    Biochem Int; 1985 Feb; 10(2):213-20. PubMed ID: 3994733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isoniazid and Huntington's chorea.
    Perry TL
    N Engl J Med; 1978 May; 298(19):1092-3. PubMed ID: 148007
    [No Abstract]   [Full Text] [Related]  

  • 16. Brain distribution of hydrazine and its GABA elevating effect in rats.
    Matsuyama K; Sendo T; Yamashita C; Sugiyama K; Noda A; Iguchi S
    J Pharmacobiodyn; 1983 Feb; 6(2):136-8. PubMed ID: 6864437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A controlled trial of isoniazid therapy for action tremor in multiple sclerosis.
    Bozek CB; Kastrukoff LF; Wright JM; Perry TL; Larsen TA
    J Neurol; 1987 Jan; 234(1):36-9. PubMed ID: 3546605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Neurochemical abnormalities in Huntington's disease].
    Korczyn AD; Eshel Y
    Harefuah; 1983 Apr; 104(8):353-5. PubMed ID: 6232180
    [No Abstract]   [Full Text] [Related]  

  • 19. [GABA and diseases of the extrapyramidal system].
    Carrieri P
    Acta Neurol (Napoli); 1977; 32(5):697-704. PubMed ID: 22223
    [No Abstract]   [Full Text] [Related]  

  • 20. GABA and movement disorders.
    Marsden CD; Sheehy MP
    Adv Biochem Psychopharmacol; 1981; 30():225-34. PubMed ID: 6460427
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.